Methamphetamine Toxicities and Clinical Management
- PMID: 38320504
- PMCID: PMC11458184
- DOI: 10.1056/EVIDra2300160
Methamphetamine Toxicities and Clinical Management
Abstract
Methamphetamine Toxicities and Clinical ManagementMethamphetamine increases the release and blocks the uptake of norepinephrine, serotonin, and dopamine. This article reviews the morbidity and mortality associated with methamphetamine use and discusses prevention and treatment strategies.
Figures



Similar articles
-
[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.Synapse. 1998 Sep;30(1):97-106. doi: 10.1002/(SICI)1098-2396(199809)30:1<97::AID-SYN12>3.0.CO;2-M. Synapse. 1998. PMID: 9704886
-
Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex.Neurochem Res. 2004 Jul;29(7):1437-42. doi: 10.1023/b:nere.0000026409.76261.f3. Neurochem Res. 2004. PMID: 15202777
-
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine.J Neurosci. 1995 Feb;15(2):1308-17. doi: 10.1523/JNEUROSCI.15-02-01308.1995. J Neurosci. 1995. PMID: 7869099 Free PMC article.
-
Are dopamine, norepinephrine, and serotonin precursors of biologically reactive intermediates involved in the pathogenesis of neurodegenerative brain disorders?Adv Exp Med Biol. 2001;500:373-96. doi: 10.1007/978-1-4615-0667-6_61. Adv Exp Med Biol. 2001. PMID: 11764972 Review. No abstract available.
-
Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.Clin Toxicol (Phila). 2010 Aug;48(7):695-708. doi: 10.3109/15563650.2010.516263. Clin Toxicol (Phila). 2010. PMID: 20849328 Review.
Cited by
-
Identification of Behavioral, Clinical, and Psychological Antecedents of Acute Stimulant Poisoning: Development and Implementation of a Mixed Methods Psychological Autopsy Study.JMIR Form Res. 2025 Jan 13;9:e64873. doi: 10.2196/64873. JMIR Form Res. 2025. PMID: 39815401 Free PMC article.
-
Clinical progress note: Management of the hospitalized patient who uses methamphetamine.J Hosp Med. 2025 Apr;20(4):380-384. doi: 10.1002/jhm.13521. Epub 2024 Oct 3. J Hosp Med. 2025. PMID: 39363482 Free PMC article. No abstract available.
-
Stimulant-Involved Cardiovascular Disease Mortality and Life Years Lost, 2014 to 2023.Subst Use. 2025 May 26;19:29768357251342744. doi: 10.1177/29768357251342744. eCollection 2025 Jan-Dec. Subst Use. 2025. PMID: 40433441 Free PMC article.
-
Trends, characteristics, and circumstances surrounding stimulant toxicity deaths in Ontario, Canada from 2018 to 2021.J Subst Use Addict Treat. 2025 Mar;170:209614. doi: 10.1016/j.josat.2024.209614. Epub 2024 Dec 21. J Subst Use Addict Treat. 2025. PMID: 39716518 Free PMC article.
-
A review of methamphetamine use and stroke in the young.Front Neurol. 2024 Apr 24;15:1397677. doi: 10.3389/fneur.2024.1397677. eCollection 2024. Front Neurol. 2024. PMID: 38721123 Free PMC article. Review.
References
-
- Methamphetamine hydrochloride [package insert]. Barceloneta, PR: AbbVie LTD; 2017.
-
- Swathi PA. National trends in methamphetamine-related psychiatric hospitalizations int he United States, 2015–2019. presented at: College on Problems of Drug Dependence 8th Scientific Meeting; 16 June 2023 2023; Denver CO.